Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2018-02-24
DOI
10.1080/21691401.2018.1439835
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of epigenome in tumorigenesis and drug resistance
- (2017) Qidong Hu et al. FOOD AND CHEMICAL TOXICOLOGY
- Small molecule selectively suppresses MYC transcription in cancer cells
- (2017) Claire Bouvard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Up-Regulation of Carbonyl Reductase 1 Renders Development of Doxorubicin Resistance in Human Gastrointestinal Cancers
- (2015) Toshiyuki Matsunaga et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- NME2 Reduces Proliferation, Migration and Invasion of Gastric Cancer Cells to Limit Metastasis
- (2015) Yan-fei Liu et al. PLoS One
- Managing the changing burden of cancer in Asia
- (2014) Rengaswamy Sankaranarayanan et al. BMC Medicine
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Knockdown of EpCAM Enhances the Chemosensitivity of Breast Cancer Cells to 5-fluorouracil by Downregulating the Antiapoptotic Factor Bcl-2
- (2014) Jiujiao Gao et al. PLoS One
- Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)
- (2013) G. von Minckwitz et al. ANNALS OF ONCOLOGY
- Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome
- (2013) Emman Shubbar et al. BMC CANCER
- A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic Intervention
- (2013) Roland Rad et al. CANCER CELL
- Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
- (2013) Min-Ae Song et al. PLoS One
- c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
- (2012) Zuqin Nie et al. CELL
- Genetic heterogeneity and cancer drug resistance
- (2012) Nicholas C Turner et al. LANCET ONCOLOGY
- DNA methylation profiling in the clinic: applications and challenges
- (2012) Holger Heyn et al. NATURE REVIEWS GENETICS
- Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer
- (2011) H. Iwata et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Drugging Drug Resistance
- (2010) Jan-Hermen Dannenberg et al. CELL
- Epigenetic modifications and human disease
- (2010) Anna Portela et al. NATURE BIOTECHNOLOGY
- Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis
- (2010) Ryan T. Bushey et al. Pharmacogenetics and Genomics
- The ups and downs of Myc biology
- (2009) Laura Soucek et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The mammalian Nm23/NDPK family: from metastasis control to cilia movement
- (2009) Mathieu Boissan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression
- (2008) Ram Krishna Thakur et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now